drugset / Trial / NCT06104488
A Study of Avutometinib for People With Solid Tumor Cancers
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to find out whether avutometinib is a safe treatment for advanced or recurrent solid tumor cancers in children and young adults. Researchers will look for the highest dose of avutometinib that is safe and cause few or mild side effects.
Timeline
- Start
- 2023-10-20
- Primary completion
- 2029-10-20
- Completion
- 2029-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avutometinib | Small molecule | — | Oral |